Wellington Partners
European venture capital firm focused on life science investing.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Wellington Partners Advisory AG
- Entity type
- COMPANY
- Founded
- 1998
- Headquarters
- Türkenstraße 5, 80333 Munich, Germany
- Company size
- 10–49
- Official website
- wellington-partners.com
What Wellington Partners does
Wellington Partners operates as a specialist venture capital manager. It raises closed-end investment funds from institutional investors, allocates that capital into early- and growth-stage life science companies, and seeks returns through exits such as acquisitions, secondary sales and public listings. It creates value by combining capital provision with sector expertise, board-level support, portfolio guidance and cross-border network access in European life sciences.
Category differentiation
This company is a venture capital fund manager focused on life sciences, not a biotech developer, healthcare provider or software vendor. It should also be distinguished from similarly named financial advisory or wealth management businesses.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Wellington Partners is a private European venture capital firm focused on early- and growth-stage life science companies. It manages investment funds, deploys capital into startups and scale-ups in the life sciences sector, and supports portfolio companies through its partner network and sector expertise. The firm operates from Germany and maintains a multi-office footprint across Europe and the United States. Its customers are institutional limited partners that commit capital to Wellington-managed funds, while its operating counterparties are life science founders and management teams seeking equity financing. Wellington Partners generates revenue through fund management economics, primarily management fees on committed capital and performance-based carried interest on successful exits. The firm is an independent specialist investor rather than an operating biotech company or software provider.
Business model & monetisation
The firm monetises through venture capital fund economics. Its primary revenue source is recurring management fees charged on committed or managed capital across its funds. A secondary revenue source is carried interest tied to realised investment gains when portfolio companies exit successfully. It does not rely on product subscriptions, advertising, transaction processing or retail sales.
- Fund management fees
- Service Fee
- Carried interest on realised exits
- Percentage Take-Rate
Products & capabilities
No products with linked sources are available in this view.
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
No sufficiently sourced and dated signals are available for this view.
Explore company relationships
Questions about Wellington Partners
What is Wellington Partners?
Wellington Partners is a private European venture capital firm that invests in early- and growth-stage life science companies.
Who uses Wellington Partners?
Its direct customers are institutional limited partners investing into its funds, and its portfolio counterparties are life science founders and management teams seeking venture capital.
How does Wellington Partners make money?
It earns recurring management fees on the funds it manages and carried interest from successful portfolio exits.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
13 publicly documented primary sources and citations linked across the market graph.
Continue your research on Wellington Partners
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.